117 related articles for article (PubMed ID: 8138968)
1. Cytochrome P450 2B enzyme induction defect after 2,2',4,4',5,5'-hexachlorobiphenyl treatment in the fa/fa Zucker rat.
Zannikos PN; Bandyopadhyay AM; Robertson LW; Blouin RA
J Pharmacol Exp Ther; 1994 Mar; 268(3):1565-70. PubMed ID: 8138968
[TBL] [Abstract][Full Text] [Related]
2. Xenobiotic-enhanced expression of cytochrome P450 2E1 and 2B1/2B2 in primary cultured rat hepatocytes.
Zangar RC; Woodcroft KJ; Kocarek TA; Novak RF
Drug Metab Dispos; 1995 Jul; 23(7):681-7. PubMed ID: 7587954
[TBL] [Abstract][Full Text] [Related]
3. Different contributions of cytochrome P450 2E1 and P450 2B1/2 to chloroform hepatotoxicity in rat.
Nakajima T; Elovaara E; Okino T; Gelboin HV; Klockars M; Riihimäki V; Aoyama T; Vainio H
Toxicol Appl Pharmacol; 1995 Aug; 133(2):215-22. PubMed ID: 7645016
[TBL] [Abstract][Full Text] [Related]
4. Effect of nutritional obesity on the induction of CYP2B enzymes following phenobarbital treatment.
Zannikos PN; Bandyopadhyay AM; Robertson LW; Blouin RA
Drug Metab Dispos; 1993; 21(5):782-7. PubMed ID: 7902236
[TBL] [Abstract][Full Text] [Related]
5. A markedly diminished pleiotropic response to phenobarbital and structurally-related xenobiotics in Zucker rats in comparison with F344/NCr or DA rats.
Lubet RA; Nims RW; Dragnev KH; Jones CR; Diwan BA; Devor DE; Ward JM; Miller MS; Rice JM
Biochem Pharmacol; 1992 Mar; 43(5):1079-87. PubMed ID: 1554380
[TBL] [Abstract][Full Text] [Related]
6. Phenobarbital in the genetically obese Zucker rat. II. In vivo and in vitro assessments of microsomal enzyme induction.
Brouwer KL; Kostenbauder HB; McNamara PJ; Blouin RA
J Pharmacol Exp Ther; 1984 Dec; 231(3):654-9. PubMed ID: 6502519
[TBL] [Abstract][Full Text] [Related]
7. Induction of liver cytochrome P450 2B1 by beta-ionone in Sprague Dawley rats.
Jeong TC; Kim HJ; Yun CH; Lee SS; Yang KH; Han SS; Roh JK
Biochem Biophys Res Commun; 1995 Nov; 216(1):198-202. PubMed ID: 7488088
[TBL] [Abstract][Full Text] [Related]
8. Strychnine and brucine as the potent inducers of drug metabolizing enzymes in rat liver: different profiles from phenobarbital on the induction of cytochrome P450 and UDP-glucuronosyltransferase.
Fujisaki H; Mise M; Ishii Y; Yamada H; Oguri K
J Pharmacol Exp Ther; 1994 Feb; 268(2):1024-31. PubMed ID: 7906730
[TBL] [Abstract][Full Text] [Related]
9. A pleiotropic response to phenobarbital-type enzyme inducers in the F344/NCr rat. Effects of chemicals of varied structure.
Lubet RA; Dragnev KH; Chauhan DP; Nims RW; Diwan BA; Ward JM; Jones CR; Rice JM; Miller MS
Biochem Pharmacol; 1992 Mar; 43(5):1067-78. PubMed ID: 1372805
[TBL] [Abstract][Full Text] [Related]
10. Phenobarbital induction and acetaminophen hepatotoxicity: resistance in the obese Zucker rodent.
Blouin RA; Dickson P; McNamara PJ; Cibull M; McClain C
J Pharmacol Exp Ther; 1987 Nov; 243(2):565-70. PubMed ID: 3681696
[TBL] [Abstract][Full Text] [Related]
11. Localization of a phenobarbital-responsive element (PBRE) in the 5'-flanking region of the rat CYP2B2 gene.
Trottier E; Belzil A; Stoltz C; Anderson A
Gene; 1995 Jun; 158(2):263-8. PubMed ID: 7607552
[TBL] [Abstract][Full Text] [Related]
12. Modulation of xenobiotic-inducible cytochrome P450 gene expression by dexamethasone in primary rat hepatocytes.
Sidhu JS; Omiecinski CJ
Pharmacogenetics; 1995 Feb; 5(1):24-36. PubMed ID: 7773300
[TBL] [Abstract][Full Text] [Related]
13. Effects of tamoxifen administration on the expression of xenobiotic metabolizing enzymes in rat liver.
Nuwaysir EF; Dragan YP; Jefcoate CR; Jordan VC; Pitot HC
Cancer Res; 1995 Apr; 55(8):1780-6. PubMed ID: 7712488
[TBL] [Abstract][Full Text] [Related]
14. Cholesteryl-conjugated phosphorothioate oligodeoxynucleotides modulate CYP2B1 expression in vivo.
Desjardins J; Mata J; Brown T; Graham D; Zon G; Iversen P
J Drug Target; 1995; 2(6):477-85. PubMed ID: 7773609
[TBL] [Abstract][Full Text] [Related]
15. Regulation of cytochrome P450 2B1/2 mRNAs by Kepone (chlordecone) and potent estrogens in primary cultures of adult rat hepatocytes on Matrigel.
Kocarek TA; Schuetz EG; Guzelian PS
Toxicol Lett; 1994 Apr; 71(2):183-96. PubMed ID: 7513451
[TBL] [Abstract][Full Text] [Related]
16. Phenobarbital induction of CYP2B1, CYP2B2, and CYP3A1 in rat liver: genetic differences in a common regulatory mechanism.
Larsen MC; Jefcoate CR
Arch Biochem Biophys; 1995 Aug; 321(2):467-76. PubMed ID: 7646073
[TBL] [Abstract][Full Text] [Related]
17. Effects of the anticonvulsant, valproate, on the expression of components of the cytochrome-P-450-mediated monooxygenase system and glutathione S-transferases.
Rogiers V; Akrawi M; Vercruysse A; Phillips IR; Shephard EA
Eur J Biochem; 1995 Jul; 231(2):337-43. PubMed ID: 7635145
[TBL] [Abstract][Full Text] [Related]
18. Intratumoral activation and enhanced chemotherapeutic effect of oxazaphosphorines following cytochrome P-450 gene transfer: development of a combined chemotherapy/cancer gene therapy strategy.
Chen L; Waxman DJ
Cancer Res; 1995 Feb; 55(3):581-9. PubMed ID: 7834628
[TBL] [Abstract][Full Text] [Related]
19. Phenobarbital induction of cytochromes P-450. High-level long-term responsiveness of primary rat hepatocyte cultures to drug induction, and glucocorticoid dependence of the phenobarbital response.
Waxman DJ; Morrissey JJ; Naik S; Jauregui HO
Biochem J; 1990 Oct; 271(1):113-9. PubMed ID: 2222405
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of human recombinant interleukin-1 beta on cytochrome P-450-dependent activities in cultured fetal rat hepatocytes.
Ferrari L; Kremers P; Batt AM; Gielen JE; Siest G
Drug Metab Dispos; 1992; 20(3):407-12. PubMed ID: 1355716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
